Skip to main content
Reimbursement strategy

Market Access Strategy for Medical Devices in Europe

Strategic recommendations on the topic of market access pathways for medical devices and IVD tests

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Sustainability Publication Digest: Potential impacts to human health from climate change: A comparative life-cycle assessment of single-use versus reusable devices flexible ureteroscopes

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Sustainability Publications Digest. 

In a recent publication, Thöne et al. performed a comparative life-cycle assessment of single-use and reusable flexible ureterorenoscopes to quantify their greenhouse gas emissions and health impacts within a German hospital setting. The study demonstrated that reusable devices are associated with nearly four times fewer greenhouse gas emissions and lower Disability-Adjusted Life Years per intervention than single-use instruments. These findings underscore that medical device choices can have substantial environmental and health impacts, supporting a shift toward more sustainable healthcare solutions.

Access the full-text article here.